Galectin Therapeutics (GALT) Net Income towards Common Stockholders Growth (3y) (2013 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Income Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 1,216,509.61 Bn | 1,216,509.61 Bn | - | -10.84% |
| 2 | Alterity Therapeutics | 764,224.41 Bn | 764,224.38 Bn | - | - |
| 3 | Legend Biotech | 2,716.00 Bn | 2,715.71 Bn | 242.10 Mn | 26.38% |
| 4 | Nanobiotix | 2,248.83 Bn | 2,248.77 Bn | - | - |
| 5 | Akari Therapeutics | 1,951.18 Bn | 1,951.17 Bn | - | -46.86% |
| 6 | Vertex Pharmaceuticals | 113.69 Bn | 106.44 Bn | 2.59 Bn | 13.80% |
| 7 | Evaxion A | 64.16 Bn | 64.14 Bn | - | 34.98% |
| 8 | Regeneron Pharmaceuticals | 63.94 Bn | 55.18 Bn | 3.31 Bn | -3.84% |
| 9 | Alnylam Pharmaceuticals | 40.13 Bn | 37.12 Bn | 959.66 Mn | 47.10% |
| 10 | Galectin Therapeutics | 165.77 Mn | 151.67 Mn | - | 23.97% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 23.97% |
| Dec 31, 2025 | 19.59% |
| Sep 30, 2025 | 1.41% |
| Jun 30, 2025 | 7.80% |
| Mar 31, 2025 | 1.06% |
| Dec 31, 2024 | -18.18% |
| Sep 30, 2024 | -9.51% |
| Jun 30, 2024 | -13.46% |
| Mar 31, 2024 | -21.95% |
| Dec 31, 2023 | -8.31% |
| Sep 30, 2023 | -33.10% |
| Jun 30, 2023 | -14.09% |
| Mar 31, 2023 | -48.08% |
| Dec 31, 2022 | -27.17% |
| Sep 30, 2022 | -44.93% |
| Jun 30, 2022 | -46.70% |
| Mar 31, 2022 | -2.93% |
| Dec 31, 2021 | -29.59% |
| Sep 30, 2021 | -41.10% |
| Jun 30, 2021 | -27.50% |
| Mar 31, 2021 | -11.75% |
| Dec 31, 2020 | -41.63% |
| Sep 30, 2020 | -8.50% |
| Jun 30, 2020 | -8.72% |
| Mar 31, 2020 | 12.00% |
| Dec 31, 2019 | -2.25% |
| Sep 30, 2019 | 15.34% |
| Jun 30, 2019 | 19.28% |
| Mar 31, 2019 | -9.06% |
| Dec 31, 2018 | 12.31% |
| Sep 30, 2018 | 20.89% |
| Jun 30, 2018 | 5.91% |
| Mar 31, 2018 | 3.62% |
| Dec 31, 2017 | 11.11% |
| Sep 30, 2017 | -6.56% |
| Jun 30, 2017 | -8.83% |
| Mar 31, 2017 | 1.24% |
| Dec 31, 2016 | -16.08% |
| Sep 30, 2016 | -7.65% |
| Jun 30, 2016 | 20.60% |
| Mar 31, 2016 | -26.39% |
| Dec 31, 2015 | -22.41% |
| Sep 30, 2015 | -27.26% |
| Jun 30, 2015 | -18.23% |
| Mar 31, 2015 | -32.04% |
| Dec 31, 2014 | -2.19% |
| Sep 30, 2014 | -18.10% |
| Jun 30, 2014 | 1.75% |
| Mar 31, 2014 | -25.71% |
| Dec 31, 2013 | -27.02% |
| Sep 30, 2013 | -25.16% |
| Jun 30, 2013 | -67.55% |